On air · 2 of 3 networks
BrainsWay
- brainsway.com
- Healthcare & Life Sciences
- US
- 148 employees
BrainsWay’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 147. Watch BrainsWay with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 145 | Checked 30 Oct 2026 | See all 147 ads → | ||
| Meta | Running | 8 | Active ads on the Meta Ad Library, all countries | Checked 27 Oct 2026 | Collect them with the API → |
| Recently | 51 | Ads on the Google Ads Transparency Center | Checked 14 Oct 2026 | Collect them with the API → |
BrainsWay has 145 live LinkedIn ads. Its Facebook page had 8 active ads on 27 Oct 2026, and we recorded 51 Google ads on 14 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 25 Nov 2024
- LINKEDIN · IMAGERecorded 11 Sept 2026
🚨 Featured in MassDevice 🚨 BrainsWay has received expanded FDA clearance for our Deep TMS™ system, now including an accelerated treatment protocol for Major Depressive Disorder (MDD) and patients with comorbid anxiety symptoms. 🔹 6 treatment days vs. 4 weeks under the standard protocol 🔹 Each session lasts less than 10 minutes 🔹 Supported by a multicenter, randomized, controlled study 🔹 Comparable efficacy with fewer clinic visits 👉 Read the full MassDevice feature: https://lnkd.in/eHMBefcf
- LINKEDIN · IMAGERecorded 11 Sept 2026
✨ Breaking News ✨ BrainsWay has officially received FDA clearance for our Accelerated Deep TMS™ protocol to treat Major Depressive Disorder (MDD). This breakthrough gives patients a faster and non-invasive pathway to relief with no fMRI neuro-navigation required. We are proud to advance the accessibility of mental health care worldwide. Read the full announcement https://lnkd.in/ec5qZXY7
- LINKEDIN · IMAGERecorded 11 Sept 2026
Two advanced treatments. One better outcome for treatment-resistant patients. Watch our free on-demand webinar with Dr. Sandhya Prashad to learn clinical insights, workflows, and best practices for combining TMS and ketamine.
- LINKEDIN · IMAGERecorded 11 Sept 2026
A Promising Approach for Tough-to-Treat Depression For patients who haven’t responded to standard treatments, combining ketamine with Deep Transcranial Magnetic Stimulation (Deep TMS™) may offer new hope. As Dr. Colleen Hanlon, BrainsWay’s VP of Global Medical Affairs, explained to Healio: ⚡ Ketamine can bring rapid relief, especially for acute symptoms. 🧠 Deep TMS™ builds lasting changes over time, with high response and remission rates that can last months. Used in sequence — often starting with ketamine and followed by Deep TMS™ — the two treatments may work together to improve outcomes for patients with refractory depression. Read more about this coordinated approach and Dr. Hanlon’s insights. https://lnkd.in/eMb9tHfZ #BrainsWay #DeepTMS #DepressionCare #MentalHealth #KetamineTherapy
- LINKEDIN · CAROUSELRecorded 8 Oct 2026
Compare BrainsWay to first generation TMS and discover deeper, broader brain stimulation with proven clinical outcomes.
6 of 147 adsSign up to see every BrainsWay ad, filter by format and date, and get alerts on new ones.
See all 147 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.